Advanced, unresectable squamous cell cancer (SCC) of the Head and Neck (H&N) remains an incurable disease in spite of aggressive surgical and/or radiation therapy. Single and combination chemotherapy has been added to surgery and/or radiation therapy in an attempt to improve this outcome. Impressive cytoreduction has been achieved with cis-platinum containing regimens with overall response rates between 80 and 90% and complete response rates in the range of 50-60% having been reported. In the last six years over 300 such patients have been treated with these regimens at Wayne State University. During these trials both favorable and unfavorable prognostic groups have been identified on the basis of clinical presentation and initial response to chemotherapy. Careful review of these trials has failed to identify clinical or morphological criteria that pretherapeutically recognize or predict these prognostically important subgroups on an individual patient basis. Recently, cellular parameters determined by flow cytometry (FCM) particularly cellular DNA content as defined by DNA index (DI) and percent S phase fraction (SPF), have been reported to correlate with response to chemotherapy, survival and biological behavior in large heterogenous groups of tumors as well as certain individual tumors. This application proposes to investigate the possibility of identifying therapeutically and prognostically important subgroups of SCC of H&N using FCM determined cellular parameters. Such identification would allow the appropriate stratification of clinical trials, the design of more aggressive protocols for poor prognostic groups and the ability to recognize and study the biological differences between these clinical subgroups.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA040498-01A1
Application #
3180540
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1986-05-01
Project End
1989-04-30
Budget Start
1986-05-01
Budget End
1987-04-30
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
El-Rayes, Basil F; Norton, Camille S; Sakr, Wael et al. (2005) Cellular DNA content parameters as prognostic indicators in human astrocytomas. J Neurooncol 71:85-9
Ensley, J F; Maciorowski, Z (1994) Clinical applications of DNA content parameters in patients with squamous cell carcinomas of the head and neck. Semin Oncol 21:330-9
Ensley, J F; Maciorowski, Z; Hassan, M et al. (1993) Variations in DNA aneuploid cell content during tumor dissociation in human colon and head and neck cancers analyzed by flow cytometry. Cytometry 14:550-8
Ensley, J F; Maciorowski, Z; Pietraszkiewicz, H et al. (1990) Methodology and clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck. Cancer Treat Res 52:225-42
Ensley, J F; Kish, J A; Weaver, A A et al. (1989) The correlation of specific variables of tumor differentiation with response rate and survival in patients with advanced head and neck cancer treated with induction chemotherapy. Cancer 63:1487-92
Ensley, J F; Maciorowski, Z; Hassan, M et al. (1989) Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry 10:334-8
Ensley, J F; Maciorowski, Z; Pietraszkiewicz, H et al. (1987) Solid tumor preparation for flow cytometry using a standard murine model. Cytometry 8:479-87
Ensley, J F; Maciorowski, Z; Pietraszkiewicz, H et al. (1987) Solid tumor preparation for clinical application of flow cytometry. Cytometry 8:488-93